Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 3314
  • Home
  • Print this page
  • Email this page

    Article Cited by others

BRIEF REPORTS

RPE Atrophy following Photodynamic Therapy in Type 2A Idiopathic Parafoveal Telangiectasis

Shanmugam Mahesh P, Agarwal Manisha

Year : 2005| Volume: 53| Issue : 1 | Page no: 61-63

   This article has been cited by
 
1 Intravitreal Anti–Vascular Endothelial Growth Factor Therapy Versus Photodynamic Therapy for Idiopathic Choroidal Neovascularization
Hae Min Kang, Hyoung Jun Koh
American Journal of Ophthalmology. 2013; 155(4): 713
[HTML Full text]  [Google Scholar] [DOI]
2 Macular telangiectasia type 2
Peter Charbel Issa,Mark C. Gillies,Emily Y. Chew,Alan C. Bird,Tjebo F.C. Heeren,Tunde Peto,Frank G. Holz,Hendrik P.N. Scholl
Progress in Retinal and Eye Research. 2013; 34: 49
[Pubmed]  [Google Scholar] [DOI]
3 Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2)
Lihteh Wu,Teodoro Evans,J. Fernando Arevalo
Survey of Ophthalmology. 2013; 58(6): 536
[Pubmed]  [Google Scholar] [DOI]
4 FUNCTIONAL RECOVERY AFTER INTRAVITREAL BEVACIZUMAB TREATMENTS FOR IDIOPATHIC CHOROIDAL NEOVASCULARIZATION IN YOUNG ADULTS :
Retina. 2012; 32(4): 679
[HTML Full text]  [Google Scholar] [DOI]
5 EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2
Raja Narayanan,Jay Chhablani,Manish Sinha,Vivek Dave,Mudit Tyagi,Rajeev R. Pappuru,Baruch D. Kuppermann
Retina. 2012; 32(10): 2001
[Pubmed]  [Google Scholar] [DOI]
6 Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A
Nikolaos Mavrakanas, Efstratios Mendrinos, Constantin J. Pournaras, Joel Salzmann
Acta Ophthalmologica. 2009; 87(8): 930-932
[Pubmed]  [Google Scholar] [DOI]
7 Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area
Nadia Artha Dewi,Mitsuko Yuzawa,Kasumi Tochigi,Akiyuki Kawamura,Ryusaburo Mori
Japanese Journal of Ophthalmology. 2008; 52(4): 277
[Pubmed]  [Google Scholar] [DOI]
8 Verteporfin photodynamic therapy in the age of antiangiogenic therapy
Irene A Barbazetto,Beatriz S Takahashi
Expert Review of Ophthalmology. 2008; 3(4): 365
[Pubmed]  [Google Scholar] [DOI]
9 Verteporfin photodynamic therapy in the age of antiangiogenic therapy
Barbazetto, I.A., Takahashi, B.S.
Expert Review of Ophthalmology. 2008; 3(4): 365-383
[Pubmed]  [Google Scholar]
10 Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area
Dewi, N.A., Yuzawa, M., Tochigi, K., Kawamura, A., Mori, R.
Japanese Journal of Ophthalmology. 2008; 52(4): 277-281
[Pubmed]  [Google Scholar]
11 Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia
Rishi, P., Shroff, D., Rishi, E.
Graefeæs Archive for Clinical and Experimental Ophthalmology. 2008; 246(4): 619-621
[Pubmed]  [Google Scholar]
12 Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia
Mandal, S., Venkatesh, P., Abbas, Z., Vohra, R., Garg, S.
Graefeæs Archive for Clinical and Experimental Ophthalmology. 2007; 245(12): 1825-1829
[Pubmed]  [Google Scholar]
13 Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
Shanmugam, M.P., Mythri, H.M., Shetty, N.S.
Indian Journal of Ophthalmology. 2007; 55(6): 490-491
[Pubmed]  [Google Scholar]
14 Ocular photodynamic therapy - Standard applications and new indications (part 1): Review of the literature and personal experience
Mennel, S., Barbazetto, I., Meyer, C.H., Peter, S., Stur, M.
Ophthalmologica. 2007; 221(4): 216-226
[Pubmed]  [Google Scholar]
15 Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy
Máar, N., Ergun, E., Luksch, A., Stur, M.
Graefeæs Archive for Clinical and Experimental Ophthalmology. 2006; 244(10): 1262-1266
[Pubmed]  [Google Scholar]
16 Ocular changes after photodynamic therapy
Tzekov, R., Lin, T., Zhang, K.-M., Jackson, B., Oyejide, A., Orilla, W., Kulkarni, A.D., (...), Burke, J.
Investigative Ophthalmology and Visual Science. 2006; 47(1): 377-385
[Pubmed]  [Google Scholar]

 

Read this article